GSK spins out corporate VC fund focused on bioelectronic tech

Posted on by admin


GSK has of­floaded a cor­po­rate ven­ture unit that in­vests in bio­elec­tron­ic star­tups work­ing on neu­ro­mod­u­la­tion, wear­ables, im­plant­ed de­vices and oth­er tech­nol­o­gy, End­points News has learned …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Related Posts